26 September 2024 - BEAM AllianceNew York, From inside the UN buildings – Remko van LeeuwenJust a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…read more >>
17 September 2024 - BEAM AllianceBEAM’s Reflection paper on General Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving ForwardThe BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…read more >>
24 October 2023 - BEAM AllianceBEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical LegislationWe call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…read more >>
05 September 2023 - BEAM AllianceBEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics SegmentThe new Task Force is gathering innovative SMEs operating in the AMR field and external experts.read more >>
16 June 2023 - BEAM AllianceBEAM’s reflection paper on the possible roles of DG HERAThe report represents an important step towards the implementation of a tangible solution to fix the AMR market. Although the…read more >>
23 May 2023 - BEAM AllianceBEAM’s statement on the EU Council Recommendation on AMRThe proposal examines AMR in a rather exhaustive way. It includes provisions on the need to strengthen national action plans,…read more >>
16 December 2024 - BasileaBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesCeftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced generation cephalosporin antibiotic for intravenous administration, with rapid…read more >>
25 November 2024 - Centauri Therapeutics LtdCentauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives“We are excited to have support from PACE as we progress the development of our molecules in anti-infectives, and de-risk…read more >>
21 November 2024 - Debiopharm InternationalCARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae InfectionsNow more than ever, new antibiotics are needed to avoid serious public health consequences caused by this infection.read more >>
13 November 2024 - AktheliaAkthelia Pharmaceuticals featured in Icelandic newspaper ViðskiptablaðiðThe article highlights the opportunity to advance our highly promising oral NCE therapeutic asset Gastrimod™️ (AKT-011) that we are exploring…read more >>
04 November 2024 - PHAXIAMPHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.This FDA IND clearance is a major recognition of our therapeutic approach and of our whole platform. This is a…read more >>
30 October 2024 - Thioredoxin Systems ABTXN Systems Raises SEK 25 Million Series A to Advance First-in-Class AntibioticWith its novel mechanism of action on a new target, and extensive testing that has demonstrated its effectiveness against a…read more >>
29 April 2021REVIVE Webinar: AMR R&D efforts in the CMC and formulation arena: Do it right the first time!REVIVE is a space for everybody with an interest in antimicrobial R&D. The Global Antibiotic Research and Development Partnership (GARDP)…read more >>
20 April 2021Anti-Infectives Drug Development – Digital EventInfectious diseases are one of the largest threats to global public health. The focus on the threat has never been…read more >>
22 March 2021BIO-Europe Spring® Digital — 15th International Partnering ConferenceThe fifteenth annual BIO-Europe Spring® conference is the premier springtime partnering conference for the life science industry. For its 2021…read more >>
04 March 2021GARDP: Learning from COVID-19 to tackle the silent pandemic of antibiotic resistanceThis webinar will focus on how we can apply the lessons learned from COVID-19 to tackle drug resistance and ensure…read more >>
25 February 2021REVIVE Webinar: From discovery to the pre-clinical antimicrobial candidateREVIVE is a space for everybody with an interest in antimicrobial R&D. The Global Antibiotic Research and Development Partnership (GARDP)…read more >>
14 January 2021REVIVE Webinar: Manipulating the host response to treat infectionsPresentations: 1.) Immune modulation and host directed therapies as an adjunctive approach to treating infections (R.E.W. (Bob) Hancock): - Host…read more >>
11 January 2021Biotech Showcase™ Digital 2021Biotech Showcase™ Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an…read more >>
20 November 2020REVIVE Webinar: Saving childrens’ lives – treating neonatal sepsisThe webinar, organized in collaboration with WHO, is being held on the occasion of Universal Children’s Day and during World…read more >>
19 November 2020XIV European Patients’ Rights Day 2020 – Towards an AMR citizens’ allianceThe XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…read more >>
